EE345 Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2-Months Is Cost Effective for the Treatment of HIV-1 in Spain
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.591
https://www.valueinhealthjournal.com/article/S1098-3015(22)02795-4/fulltext
Title :
EE345 Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2-Months Is Cost Effective for the Treatment of HIV-1 in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02795-4&doi=10.1016/j.jval.2022.09.591
First page :
Section Title :
Open access? :
No
Section Order :
10123